欧康维视提示
本内容仅供医学专业人士使用。如果您是医学专业人士，请点击确认，进入页面；否则请点击退出，返回上一页。
Home/Investors/Public Disclosure/Announcements and Circulars
Announcements and Circulars
2020-12-29
VOLUNTARY ANNOUNCEMENT FIRST PATIENT ENROLLED IN THE PHASE III CLINICAL TRIAL OF OT-1001 (ZERVIATE) IN CHINA
2020-12-28
VOLUNTARY ANNOUNCEMENT OT-401 APPROVED FOR REAL WORLD STUDY IN HAINAN BOAO
2020-12-28
CHANGE OF ADDRESS OF HEAD OFFICE AND PRINCIPAL PLACE OF BUSINESS IN THE PRC
2020-12-03
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 November 2020
2020-11-30
VOLUNTARY ANNOUNCEMENT INITIATION OF OT-401 REAL WORLD STUDY IN HAINAN
2020-11-11
VOLUNTARY ANNOUNCEMENT INITIATION OF SECOND PHASE III CLINICAL TRIAL OF OT-301 IN THE UNITED STATES
2020-11-05
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 October 2020
2020-10-30
VOLUNTARY ANNOUNCEMENT ENTERING INTO COLLABORATION AND EXCLUSIVE PROMOTION AGREEMENT WITH LUYE PHARMA
2020-10-23
VOLUNTARY ANNOUNCEMENT PHASE III CLINICAL TRIAL OF OT-301 (NCX 470) APPROVED IN CHINA
2020-10-07
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 September 2020
2020-09-29
Notification Letter and Request Form for Non-Registered Shareholders
2020-09-29
Letter to Shareholders - Election of Language and Means of Receipt of Corporate Communications
2020-09-29
ELECTION OF LANGUAGE AND MEANS OF RECEIPT OF CORPORATE COMMUNICATIONS
2020-09-29
2020 Interim Report
2020-09-22
VOLUNTARY ANNOUNCEMENT PHASE III CLINICAL TRIAL OF OT-1001 (ZERVIATE) APPROVED IN CHINA
2020-09-11
ANNOUNCEMENT ACQUISITION OF 100% EQUITY INTEREST IN SUZHOU XIAXIANG AND CHANGE IN USE OF PROCEEDS FROM THE LISTING
2020-09-03
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 August 2020
2020-08-26
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2020
2020-08-14
NOTICE OF BOARD MEETING
2020-08-05
Next Day Disclosure Return
2020-08-05
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 July 2020
2020-08-02
FULL EXERCISE OF THE OVER-ALLOTMENT OPTION, STABILIZING ACTIONS AND END OF STABILIZATION PERIOD
2020-07-09
List of Directors and their Role and Function
2020-07-09
TERMS OF REFERENCE OF THE REMUNERATION COMMITTEE
2020-07-09
TERMS OF REFERENCE OF THE NOMINATION COMMITTEE
2020-07-09
TERMS OF REFERENCE OF THE AUDIT COMMITTEE
2020-07-09
AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION
2020-07-09
ANNOUNCEMENT OF OFFER PRICE AND ALLOTMENT RESULTS
2020-06-29
GREEN APPLICATION FORM
2020-06-29
YELLOW APPLICATION FORM
2020-06-29
WHITE APPLICATION FORM
2020-06-29
GLOBAL OFFERING
2020-06-29
GLOBAL OFFERING
2020-06-21
PHIP (1st submission)
2020-06-21
PHIP (1st submission)
2020-04-29
Application Proof (1st submission)
2020-04-29
Application Proof (1st submission)
Follow us
